Impact of Roflumilast in Asthma-Copd Overlap Syndrome on Systemic Inflammation and Humoral Anti-Endotoxin Immunity.
Phase of Trial: Phase II
Latest Information Update: 18 Mar 2016
At a glance
- Drugs Roflumilast (Primary) ; Fluticasone propionate; Salmeterol
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 18 Mar 2016 New trial record